These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8074020)

  • 1. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
    Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
    Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects.
    Lehmann G; Hähnel I; Reiniger G; Lampen M; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):212-20. PubMed ID: 9475262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic response to molsidomine in patients with ischemic cardiomyopathy tolerant to isosorbide dinitrate.
    Unger P; Leone A; Staroukine M; Degré S; Berkenboom G
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):888-94. PubMed ID: 1725903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril.
    Mehra A; Ostrzega E; Shotan A; Johnson JV; Elkayam U
    Am J Cardiol; 1992 Nov; 70(15):1310-4. PubMed ID: 1442583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual isosorbide dinitrate in severe congestive heart failure.
    Markiewicz W; Rochman J; Peled B
    Cardiology; 1981; 67(3):172-9. PubMed ID: 7273045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nitrates in the treatment of heart failure].
    Dirschinger J; Hall D; Rudolph W
    Herz; 1990 Jun; 15(3):171-8. PubMed ID: 2115855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isosorbide dinitrate and exercise performance in patients with congestive heart failure.
    Franciosa JA
    Am Heart J; 1985 Jul; 110(1 Pt 2):245-50. PubMed ID: 3893080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent findings on nitrates: their action, bioactivation and development of tolerance].
    Münzel T
    Dtsch Med Wochenschr; 2008 Oct; 133(44):2277-82. PubMed ID: 18946854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of isosorbide dinitrate on submaximal exercise capacity of patients with chronic left ventricular failure.
    Wilson JR; Ferraro N
    Chest; 1982 Dec; 82(6):701-4. PubMed ID: 7140397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA; Russell RO; Moraski RE; Rackley CE
    Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
    Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
    Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction.
    Cintron GB; Glasser SP; Weston BA; Linares E; Conti CR
    Am J Cardiol; 1988 Jan; 61(1):21-5. PubMed ID: 3122548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine.
    Lehmann G; Reiniger G; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):25-30. PubMed ID: 9456273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
    Schneeweiss A
    Am J Cardiol; 1988 Mar; 61(9):19E-21E. PubMed ID: 3126632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
    Mikulic E; Franciosa JA; Cohn JN
    Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.